Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2018
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study
D Gramatzki, P Roth, E J Rushing, et al.
Cancer Research
|
October 5, 2001
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma
C Morrissey, A Martinez, M Zatyka, et al.
British Journal of Cancer
|
June 10, 2010
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
G Kristiansen, M Rose, C Geisler, et al.
Leukemia
|
March 8, 2008
MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma
A Curioni-Fontecedro, A J Knights, M Tinguely, et al.
The Journal of Pathology
|
July 9, 1999
Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer
U Wagner, K Süess, T Luginbühl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2011
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
R von Moos, B Seifert, M Simcock, et al.
Journal of the National Cancer Institute
|
October 21, 1999
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays
L Bubendorf, M Kolmer, J Kononen, et al.
Histopathology
|
October 12, 2022
WHO 2022 classification of penile and scrotal cancers: updates and evolution
S Menon, H Moch, D M Berney, et al.
Cancer Science
|
March 1, 2008
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome
M Tinguely, B Jenni, A Knights, et al.
Oncogenesis
|
March 2, 2016
Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients
C G Stoehr, R Stoehr, A Wenners, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2018
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study
D Gramatzki, P Roth, E J Rushing, et al.
Cancer Research
|
October 5, 2001
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma
C Morrissey, A Martinez, M Zatyka, et al.
British Journal of Cancer
|
June 10, 2010
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
G Kristiansen, M Rose, C Geisler, et al.
Leukemia
|
March 8, 2008
MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma
A Curioni-Fontecedro, A J Knights, M Tinguely, et al.
The Journal of Pathology
|
July 9, 1999
Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer
U Wagner, K Süess, T Luginbühl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2011
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
R von Moos, B Seifert, M Simcock, et al.
Journal of the National Cancer Institute
|
October 21, 1999
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays
L Bubendorf, M Kolmer, J Kononen, et al.
Histopathology
|
October 12, 2022
WHO 2022 classification of penile and scrotal cancers: updates and evolution
S Menon, H Moch, D M Berney, et al.
Cancer Science
|
March 1, 2008
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome
M Tinguely, B Jenni, A Knights, et al.
Oncogenesis
|
March 2, 2016
Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients
C G Stoehr, R Stoehr, A Wenners, et al.
Page
of 19